Hyperinsulinism-hyperammonemia syndrome: A Caregiver Guide
At a Glance
HI/HA syndrome is a genetic condition in which fasting or protein-rich foods can trigger too much insulin and dangerous low blood sugar; ammonia may be mildly elevated or normal. Care combines diazoxide, individualized protein planning, glucose monitoring, and developmental follow-up.
Hyperinsulinism-hyperammonemia (HI/HA) syndrome is a rare genetic disorder that fundamentally changes how the body manages its primary fuel: sugar. This caregiver guide is designed to help parents and guardians navigate the complexities of this diagnosis.
In children with this condition, a pathogenic variant in the GLUD1 gene causes the pancreas to act like an overactive engine [1]. It inappropriately releases insulin—the hormone responsible for lowering blood sugar—particularly after exposure to protein, and sometimes during fasting. At the same time, the body’s altered nitrogen processing leads to elevated levels of ammonia. While this mild hyperammonemia is a useful diagnostic clue, it is not always present, and the primary danger of the condition is the low blood sugar [2].
The most significant challenge for families is managing the dual triggers of this condition. While most metabolic disorders cause problems only during fasting, HI/HA is unique because it is also triggered by protein [3]. An amino acid called leucine, found in common foods like eggs, meat, and dairy, acts as a direct signal to the pancreas to release insulin. This means a child’s blood sugar can crash not only after they skip a meal but also after they eat a high-protein one [4]. Because these “lows” can cause sudden seizures or loss of consciousness, many children are initially misdiagnosed with standard epilepsy before the true metabolic cause is discovered [1].
The primary danger in HI/HA is hypoglycemia (low blood sugar), which deprives the brain of the energy it needs to function [5]. Fortunately, most children respond well to a first-line medication called diazoxide, which helps “quiet” the insulin-producing cells [6]. Management is further supported by working with specialized dietitians to individualize protein intake, ensuring the child gets the nutrition they need for growth while minimizing dangerous blood sugar drops [1].
Living with HI/HA requires a long-term commitment to monitoring and proactive care under the supervision of a metabolic specialist. Beyond stabilizing blood sugar, families and medical teams must focus on the “whole child,” including regular assessments of learning, speech, and motor skills [7]. While the diagnosis can be overwhelming, a structured approach—combining the right medication, dietary adjustments, and developmental support—provides a clear framework for protecting a child’s health and helping them thrive [8].
In this guide
7 chapters
Understanding the HI/HA Diagnosis
Learn how hyperinsulinism-hyperammonemia (HI/HA) syndrome is diagnosed, including low blood sugar, ammonia testing, GLUD1 variants, and critical samples.
Symptoms, Triggers, and Warning Signs
Learn to recognize HI/HA syndrome symptoms, fasting and protein triggers, low blood sugar signs, seizure red flags, and emergency steps for children with HI/HA.
The GLUD1 Gene and How HI/HA Works
Learn how GLUD1 gene changes cause hyperinsulinism-hyperammonemia syndrome, why protein can trigger low blood sugar, and how inheritance affects your family.
Lab Tests, The Critical Sample, and Genetics
Learn how hyperinsulinism-hyperammonemia syndrome is diagnosed: critical sample results, insulin, ketones, ammonia, glucagon testing, and genetic testing.
Medical Treatment and Clinical Protocols
Learn how HI/HA syndrome is treated with diazoxide, chlorothiazide, safety monitoring, emergency care, and specialist options for children with GLUD1 variants.
Dietary Management and Daily Life
Learn how HI/HA syndrome care balances protein and fasting, with CGM limits, sick-day planning, glucose rescue, and school safety steps for your child.
Long-Term Monitoring and Life After Diagnosis
Learn about long-term monitoring for hyperinsulinism-hyperammonemia syndrome, including development, seizures, diazoxide safety checks, and caregiver support.
Common questions in this guide
What causes hyperinsulinism-hyperammonemia syndrome?
Why can protein trigger low blood sugar in HI/HA syndrome?
What is the main health risk of HI/HA syndrome?
How is HI/HA syndrome treated and managed?
Can HI/HA syndrome be mistaken for epilepsy?
Why does a child with HI/HA syndrome need developmental follow-up?
Get notified when new evidence is published on Hyperinsulinism-hyperammonemia syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (8)
- 1
Hyperinsulinism-hyperammonemia syndrome in two Peruvian children with refractory epilepsy.
De Los Santos-La Torre MA, Del Águila-Villar CM, Lu-de Lama LR, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2023; (36(2)):207-211 doi:10.1515/jpem-2022-0490.
PMID: 36476334 - 2
Hyperinsulinism-hyperammonemia Syndrome in an Infant with Seizures.
Strajnar A, Tansek MZ, Podkrajsek KT, et al.
Balkan journal of medical genetics : BJMG 2018; (21(1)):77-81 doi:10.2478/bjmg-2018-0014.
PMID: 30425915 - 3
Congenital Hyperinsulinemic Hypoglycemia and Hyperammonemia due to Pathogenic Variants in GLUD1.
Roy K, Satapathy AK, Houhton JAL, et al.
Indian journal of pediatrics 2019; (86(11)):1051-1053 doi:10.1007/s12098-019-02980-x.
PMID: 31119523 - 4
Identification of the molecular dysfunction caused by glutamate dehydrogenase S445L mutation responsible for hyperinsulinism/hyperammonemia.
Grimaldi M, Karaca M, Latini L, et al.
Human molecular genetics 2017; (26(18)):3453-3465 doi:10.1093/hmg/ddx213.
PMID: 28911206 - 5
Reverse Phenotyping: Addressing Refractory Seizures From an Endocrine Perspective.
Sherin S, Soodhana D, Mohanlal S, Pachat D
Cureus 2024; (16(12)):e75146 doi:10.7759/cureus.75146.
PMID: 39759686 - 6
Clinical and Molecular Spectrum of Glutamate Dehydrogenase Gene Defects in 26 Chinese Congenital Hyperinsulinemia Patients.
Su C, Liang XJ, Li WJ, et al.
Journal of diabetes research 2018; (2018()):2802540 doi:10.1155/2018/2802540.
PMID: 30306091 - 7
Spectrum of neuro-developmental disorders in children with congenital hyperinsulinism due to activating mutations in GLUD1.
Aftab S, Gubaeva D, Houghton JAL, et al.
Endocrine connections 2023; (12(4)).
PMID: 35951311 - 8
Congenital Hyperinsulinism International: A Community Focused on Improving the Lives of People Living With Congenital Hyperinsulinism.
Raskin J, Pasquini TLS, Bose S, et al.
Frontiers in endocrinology 2022; (13()):886552 doi:10.3389/fendo.2022.886552.
PMID: 35573986
This caregiver guide is for informational purposes only and does not constitute medical advice. Your child's metabolic specialist and care team should guide decisions about diazoxide, protein intake, blood sugar monitoring, and developmental follow-up.